Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin‐Induced Nephrotoxicity

Key Points

• The scoring model may enhance prediction of vancomycin-induced nephrotoxicity, improving patient safety in clinical settings.
• Using risk factors along with pharmacokinetic parameters, the model provides a new method for assessing nephrotoxicity risk.
• Assessment integrates clinical data to tailor dosing strategies, which could lead to better patient outcomes and lower incidence of kidney injury.
• The findings are significant for developing personalized medicine approaches, emphasizing the need for further validation in broader populations.

Abstract